Carmat: CE marking for its total artificial heart December 23, 2020 CE marking allows the company to market its total artificial heart in the EU as a bridge to transplant Virtual press conference scheduled on January 6, 2021 Download PDF Carmat First-of its kind implantable artificial heart
December 22, 2020 Abivax’s Covid-19 Phase 2B/3 MIR-AGE trial with ABX464 declared Research National Priority by the French government’s clinical trial council
December 21, 2020 Abivax to present at the 39th annual J.P. Morgan Healthcare Conference ahead of major clinical milestones
December 11, 2020 Discussion of Abivax Clinical Program involving Covid-19, Ulcerative Colitis, Crohn’s Disease and more
December 9, 2020 Abivax establishes clinical, regulatory and manufacturing framework for ABX464 phase 3 program and potential commercialization in 2021
December 4, 2020 Centers for Medicare & Medicaid Services (CMS) grant transitional pass-through (TPT) payment for Stryker's SpineJack® System
December 1, 2020 Abivax completes recruitment of ABX464 phase 2b induction study in ulcerative colitis
